| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.26M | 9.26M | 8.93M | 18.62M | 14.36M | 10.77M |
| Gross Profit | -3.59M | -2.81M | -949.00K | 1.67M | 2.18M | 1.03M |
| EBITDA | -9.45M | -10.81M | -5.74M | -1.36M | 1.65M | 678.63K |
| Net Income | -12.79M | -13.65M | -7.34M | -2.46M | 1.14M | 464.98K |
Balance Sheet | ||||||
| Total Assets | 22.05M | 11.31M | 14.20M | 20.85M | 11.80M | 11.27M |
| Cash, Cash Equivalents and Short-Term Investments | 61.45K | 420.13K | 221.76K | 810.37K | 1.31M | 489.85K |
| Total Debt | 8.33M | 10.38M | 8.06M | 6.25M | 136.48K | 88.50K |
| Total Liabilities | 30.19M | 25.65M | 20.92M | 20.23M | 10.03M | 10.72M |
| Stockholders Equity | -8.13M | -14.34M | -6.72M | 617.45K | 1.77M | 555.69K |
Cash Flow | ||||||
| Free Cash Flow | -4.57M | -5.93M | -1.68M | -2.51M | 2.05M | 395.29K |
| Operating Cash Flow | -4.57M | -5.93M | -1.68M | -2.45M | 2.07M | 466.21K |
| Investing Cash Flow | -863.56K | -40.00K | -437.09K | -269.77K | -1.19M | -216.93K |
| Financing Cash Flow | 5.45M | 6.17M | 1.53M | 2.22M | 41.85K | 100.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $55.91M | 10.97 | 8.20% | ― | -1.47% | 52.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $18.66M | 0.84 | 21.29% | ― | -1.36% | ― | |
59 Neutral | $4.35M | -4.26 | ― | 8.18% | -23.37% | -264.09% | |
55 Neutral | $27.68M | -147.23 | -0.73% | ― | 19.84% | 95.71% | |
44 Neutral | $320.23K | >-0.01 | ― | ― | ― | ― | |
41 Neutral | $3.03M | -0.51 | -82.18% | ― | -57.40% | 52.85% |
On December 4, 2025, Nature’s Miracle Holding Inc. filed a Certificate of Amendment to increase its authorized common stock from 100 million to 1 billion shares. This amendment, approved by the majority of shareholders, signifies a strategic move to potentially enhance the company’s financial flexibility and market presence.
The most recent analyst rating on (NMHI) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Nature’s Miracle Holding stock, see the NMHI Stock Forecast page.